Treatment
Fexofenadine clinical trials
We’re tracking 7 recruiting studies that include Fexofenadine, each written for real people, not researchers, below.
Recruiting studies
- NCT06548204RecruitingPhase 2
Antihistamine after a heart attack
This trial tests whether taking an antihistamine medicine called fexofenadine hydrochloride can help people recover better after a heart attack. It is a randomized study, so some participants will receive the medicine and others will receive a placebo (a pill with no active ingredients).
Hangzhou, ZhejiangAges 18 years+ - NCT07381803RecruitingPhase 3
Fexofenadine for heart attack recovery
This trial tests if the allergy medicine fexofenadine can improve recovery after a heart attack. You may qualify if you had a specific type of heart attack (STEMI) within the last week.
Hangzhou, ZhejiangAges 18 years+ - NCT05264025RecruitingPhase 1/Phase 2
Fexofenadine for active rheumatoid arthritis
This Phase 1/2 study tests whether fexofenadine (an allergy medicine) can improve symptoms and inflammation in people with active rheumatoid arthritis. Participants may be assigned to different treatment groups, and the study looks at safety and early signs of benefit.
Banī SuwayfAges 18–60 - NCT06785298RecruitingPhase 2/Phase 3
Fexofenadine as add-on treatment for Parkinson's disease
This trial tests whether adding fexofenadine, a common allergy medicine, to your current Parkinson's treatment can help improve symptoms. It's for people aged 50 or older who are already on dopamine replacement therapy.
TantaAges 50–70 - NCT02966665RecruitingPhase 1
Testing blood vessel function in people of different health conditions
This early study measures how well your blood vessels work using tests that may include MRI. It compares healthy people with people who have conditions like COPD, pulmonary arterial hypertension, heart failure, or high blood pressure, to better understand “vascular function” in health and disease.
Salt Lake City, UtahAges 18 years+ - NCT06152497Recruiting
Histamine and muscle growth after strength training
This study looks at how histamine affects muscle building after resistance exercise. It may help us understand why some people build muscle better than others after strength training.
Ghent, Oost-VlaanderenAges 18–45 - NCT05263206RecruitingPhase 3
Shot medicine (dupilumab) for severe, unexplained chronic itching
This Phase 3 study tests whether dupilumab injections can reduce severe itching that has no clear cause. It also checks how safe the medicine is over the study period.
Bakersfield, CaliforniaAges 18–90
What Fexofenadine is being studied for
Conditions with recruiting Fexofenadine studies.
Common questions
- Are there clinical trials studying Fexofenadine?
- Yes. Clin2 currently lists 7 recruiting studies that include Fexofenadine, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Fexofenadine trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Fexofenadine an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Fexofenadine or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.